<sent id="30">  And the success of the Brazilian program derived complimentary concerns , as Renata Reis says : `` The survival rate is very high here , so access to new second line therapy drugs has critical importance for keeping HIV infection under control by overcoming the long term patient 's growing resistance to the ARV previous treatments '' . </sent> <sent id="31">  The prices of the second line ARVs threaten the sustainability of Brazilian universal drugs distribution policy , since they can not be locally manufactured as generics . </sent> <sent id="32">  Though the country has got full capacity and ability to produce the second line ARV medicines , as attested by the document `` ARVs Production in Brazil - An Evaluation '' , by Professors Joseph M. Fortunak and Octavio A. C. Antunes indeed , until the 1990s , Brazil had national production of ARVs , a process prematurely interrupted by the pipeline mechanism .
 </sent>